Abstract
Forming an endothelial cell (EC) monolayer on the surface of blood-contacting devices is an ideal way to improve their blood compatibility, this process is known as endothelialization. Heparin is a proteoglycan with a strong negative charge, which is a commonly used antithrombotic agent. Heparin coatings also has been successfully used to improve the hemocompatibility of various biomaterials. In this study, a short peptide Arg-Glu-Asp-Val (REDV) with specific affinity for endothelial cells was covalently conjugated with maleimide-functionalized heparin. The conjugate retains the negative charge of heparin and can be directly immobilized on the surface of positively charged poly-L-lysine. This specific reaction to the carboxyl group of heparin could potentially reduce the shedding and steric hindrance effects of REDV peptide and enhancing the affinity and selectivity of heparin for EC.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
